Susan C. Modesitt, MD
Dr. Modesitt's Office & Appointments:
Dr. Modesitt is the Director of the Gynecologic Oncology Division and the Richard N. and Louse R. Crockett Professor in the Obstetrics and Gynecology Department at the University of Virginia. She also serves as the co-Director of the High Risk Breast and Ovarian Cancer and the medical director for the inpatient gynecology floors.
Some of Dr. Modesitt’s current responsibilities include being the Principal Investigator for the Gynecologic Oncology Group (GOG) at the University of Virginia as well as serving on the GOG's Safety Review Committee and the Data Safety Monitoring Board. She is on the editorial board for Obstetrics and Gynecology, Gynecologic Oncology and Gynecologic Oncology Case Reports, is a full member of the Society for Gynecologic Oncology (SGO), and is a Fellow of both the American College of Obstetricians and Gynecologists (ACOG) and the American College of Surgeons (ACS).
Dr. Modesitt has published extensively on gynecologic cancers and is recognized as one the Nation's Top Doctors for Cancer by U.S. News and World Report. Her current research focuses primarily on novel therapeutics in clinical trials, obesity related cancers, and hereditary cancers. She competes in triathlons in her spare time.
Obstetrics and Gynecology
Special Expertise ~
2012 - present Top Doctor and Top Doctor for Cancer, Castle Connolly
2011 - present U.S. News & World Report, Top doctor, Gynecologic
2010 Dean’s award for Clinical Excellence, University of Virginia School of Medicine
2010 Association of Professors of Gynecology and Obstetrics (APGO) Excellence in
2009 - present Best Doctors® in America
2006 Council on Resident Education in Obstetrics and Gynecology (CREOG) National Faculty
Award for Excellence in Residency Teaching
2005 Association of Professors of Gynecology and Obstetrics (APGO) Excellence in
1991 – BS Magna cum laude, Emory University
1995 – MD University of Virginia School of Medicine
1999 - University of North Carolina
2002 – M.D. Anderson Cancer Center
2003 - present - Diplomate, American Board of Obstetrics and Gynecology
2005 - present - Special Certification, Gynecologic Oncology
Dr. Modesitt has published extensively on Gynecologic Cancers and her current research focuses primarily on novel therapeutics in clinical trials, obesity related cancers, and hereditary cancers.
Clinical Trials ~
Dr. Modesitt is the director for the clinical trials program in Gynecologic Oncology and had open trials in obesity related cancers, gynecologic malignancies and hereditary cancers in gynecology.